title: Current management of diabetic patients with kidney disease: a renal‑cardio‑endocrine perspective.
abstract: Diabetic kidney disease (DKD) is one of the most frequent and dangerous complications of diabetes mellitus type 2, affecting about one‑third of the patients. DKD results in increased hospitalizations and mortality rates, especially due to cardiovascular complications. This high burden of kidney disease is mainly due to the increasing complexity of in- outpatient care for patients with DM. There is a strikingly complex interaction of kidney dysfunction with many aspects of diabetes care, such as redefinition of targets of treatment, interactions of traditional and non‑traditional risk factors, and pharmacological issues related to pharmacokinetic and side effects of drugs. Particularly when not carefully managed, DKD increases the demand for renal replacement therapies, such as dialysis and kidney transplants. The combined economic and social costs of this disease are high and of concern to the world's health systems. The main objective of this review is to provide insight into the recommendations for the evaluation and stratification of DKD and how the presence of kidney disease changes the optimal management of diabetic patients from an integrated renal‑cardio‑endocrine perspective.
authors.affiliation: Division of Cardiology, Endocrinology and Nephrology, School of Medicine, Pontificia Universidade Católica do Paraná, Curitiba, Brazil - r.pecoits@pucpr.br.
authors.forename: Roberto
authors.initials: R
authors.lastname: Pecoits-Filho
authors.affiliation: Division of Cardiology, Endocrinology and Nephrology, School of Medicine, Pontificia Universidade Católica do Paraná, Curitiba, Brazil.
authors.forename: José
authors.initials: J
authors.lastname: Fortes
authors.affiliation: Division of Cardiology, Endocrinology and Nephrology, School of Medicine, Pontificia Universidade Católica do Paraná, Curitiba, Brazil.
authors.forename: Aléxei
authors.initials: A
authors.lastname: Volaco
authors.affiliation: Federal University of Goiás-Postgraduate Program, Goiania, Brazil.
authors.forename: Sergio
authors.initials: S
authors.lastname: Vencio
authors.affiliation: Cardiology Division, State University of Campinas, Unicamp, Campinas, SP, Brazil.
authors.forename: Andrei C
authors.initials: AC
authors.lastname: Sposito
mesh_terms: D015190:Blood Glucose Self-Monitoring; D001794:Blood Pressure; D003924:Diabetes Mellitus, Type 2 / Q000628:therapy*; D003928:Diabetic Nephropathies / Q000628:therapy*; D004703:Endocrine System; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D065089:Glycoside Hydrolase Inhibitors / Q000627:therapeutic use; D006321:Heart / Q000503:physiopathology; D006706:Homeostasis; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy; D007003:Hypoglycemia / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D007668:Kidney / Q000503:physiopathology; D008687:Metformin / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000627:therapeutic use; D000520:alpha-Glucosidases
chemical_list: D005343:Fibrinolytic Agents; D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D007328:Insulin; D010975:Platelet Aggregation Inhibitors; D013453:Sulfonylurea Compounds; D008687:Metformin; D000520:alpha-Glucosidases